Crowdonomics
Herb & Olive, LLC

Reg CF · Convertible Note · Jan 2022

FailedReg CFConvertible Note
via MICROVENTURE MARKETPLACE INC. · last checked Aug 17, 2026
Raised
$0 / $250K max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2019–FY2020 · hover for source
$4K
−$23K
FY2019
$17K
−$9K
FY2020
RevenueNet income
Metric
FY2019 reviewed*
FY2020 reviewed*
Income statement
Revenue
$3,530
$16,778
Cost of goods sold
$26,416
$25,632
Gross margin
-648%
-53%
Net income
-$22,886
-$8,854
Taxes paid
$0
$0
Balance sheet
Cash
$3,985
$11,403
Accounts receivable
$0
$0
Total assets
$17,223
$23,849
Short-term debt
$30,645
$40,290
Long-term debt
$1,000
$47,123
Total liabilities
$31,645
$87,413
Other
Headcount
—
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. May 2, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Jan 19, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$50,000
Max$250,000
Min investment—
OpenedJan 7, 2022
DeadlineJun 6, 2022
ClosedJun 6, 2022
Days active150

Links & provenance

Source: SEC EDGAR
0001885290-22-000001
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.